LS ARK Genomic Revolution Tracker ETP Securities XS2399368062
3.64
EUR
0.27
EUR
8.12 %
16:16:03
NAV
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 3.81 USD | 0.10 USD | 2.72 % |
|---|
| Vortag | 3.71 USD | Datum | 14.09.2026 |
LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Uniswap ETP | CH1135202096 | 129.77% | |
| 21Shares Aave ETP | CH1135202120 | 62.39% | |
| 21Shares Pendle ETP | CH1495416997 | 61.09% | |
| 21shares Ethena ETP | CH1506167035 | 59.11% | |
| 21Shares Arbitrum ETP | CH1304867463 | 53.53% | |
| 21Shares Raydium ETP | CH1480821391 | 40.48% | |
| 21Shares Maple Finance ETP | CH1495416989 | 39.10% | |
| 21shares Jito Staked SOL ETP USD | CH1521714696 | 36.20% | |
| 21Shares Jupiter ETP | CH1480821383 | 14.92% | |
| 21shares Strategy Yield ETP USD | CH1528107811 | 5.01% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 111.23% | |
| 21Shares Injective Staking ETP | CH1360612134 | 79.81% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 73.56% | |
| 21Shares Pendle ETP | CH1495416997 | 73.25% | |
| 21Shares Uniswap ETP | CH1135202096 | 51.55% | |
| 21Shares Raydium ETP | CH1480821391 | 36.25% | |
| 21Shares Jupiter ETP | CH1480821383 | 33.28% | |
| 21Shares Arbitrum ETP | CH1304867463 | 29.76% | |
| 21shares Jito Staked SOL ETP USD | CH1521714696 | 13.33% | |
| 21shares Strategy Yield ETP USD | CH1528107811 | 2.92% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 42.93% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 1.28% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | -10.07% | |
| 21Shares Binance BNB ETP | CH0496454155 | -23.87% | |
| 21Shares Uniswap ETP | CH1135202096 | -33.24% | |
| 21Shares Injective Staking ETP | CH1360612134 | -58.94% | |
| 21shares XDC Network Staking ETP | CH1464217285 | -62.69% | |
| 21Shares Dogecoin ETP | CH1431521033 | -69.87% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -75.38% | |
| 21Shares Sui Staking ETP | CH1360612159 | -80.46% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares XRP ETP | CH0454664043 | 130.67% | |
| 21Shares Stellar ETP | CH1109575535 | 88.53% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 61.05% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 59.04% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | 29.82% | |
| 21Shares Sui Staking ETP | CH1360612159 | -33.01% | |
| 21Shares Injective Staking ETP | CH1360612134 | -71.09% |
Fundamentaldaten
| Valor | |
| ISIN | XS2399368062 |
| Emittent | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 10.12.2021 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 1’024’146.18 |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 16.09.2026 |
Anlagepolitik
So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.
ETP Performance: LS ARK Genomic Revolution Tracker ETP Securities
| Performance 1 Jahr | 83.37 | |
| Performance 2 Jahre | 81.34 | |
| Performance 3 Jahre | 54.62 | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |